Busulfan, Fludarabine, and Alemtuzumab Conditioning and Unrelated Cord Blood Transplantation in Children with Sickle Cell Disease

Radhakrishnan, Kavita; Bhatia, Monica; B. Geyer, Mark; Del Toro, G.; Jin, Zhezhen; E. Baker, Courtney; Harrison, Lauren; Morris, Erin; Ann Baxter‐Lowe, Lee; S. Cairo, Mitchell

doi:10.1016/j.bbmt.2013.02.002

Public

Busulfan, Fludarabine, and Alemtuzumab Conditioning and Unrelated Cord Blood Transplantation in Children with Sickle Cell Disease

Published in Biology of Blood and Marrow Transplantation • Feb 8, 2013

Authors:

Kavita Radhakrishnan

Monica Bhatia

Mark B. Geyer

Abstract

Kamani et al. [1Kamani N.R. Walters M.C. Carter S. et al.Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN).Biol Blood Marrow Transplant. 2012; 1...

Subject

Medicine

Alemtuzumab

Fludarabine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!